Get the Stockscreener App
54.73
1.45%
0.78
After Hours:
54.87
0.14
+0.26%
Hims Hers Health Inc stock is traded at $54.73, with a volume of 23.31M.
It is up +1.45% in the last 24 hours and down -1.39% over the past month.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
See More
Previous Close:
$53.95
Open:
$54.42
24h Volume:
23.31M
Relative Volume:
0.81
Market Cap:
$11.91B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
79.32
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
-0.05%
1M Performance:
-1.39%
6M Performance:
+100.99%
1Y Performance:
+192.83%
1-Day Range:
$53.84
$56.27
1-Week Range:
$53.02
$60.13
52-Week Range:
$18.32
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
54.73 | 12.19B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025 - FinancialContent
Hims & Hers: Why I’m Betting On HIMS Heading To $100 (NYSE:HIMS) - Seeking Alpha
Best Healthcare Stocks To Keep An Eye OnOctober 12th - MarketBeat
Callan Family Office LLC Grows Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Kingswood Wealth Advisors LLC Makes New $241,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Top Healthcare Stocks To Watch NowOctober 11th - MarketBeat
SLT Holdings LLC Purchases Shares of 8,125 Hims & Hers Health, Inc. $HIMS - MarketBeat
Total Wealth Planning & Management Inc. Makes New $593,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Why Hims & Hers Health (HIMS) Stock Is Nosediving - The Globe and Mail
Moderate Bearish Sentiment Surrounds HIMS as Options Activity Su - GuruFocus
Option traders moderately bearish in Hims and Hers Health with shares down 5.36% - TipRanks
Healthcare Stocks To Add to Your WatchlistOctober 10th - MarketBeat
HIMS: BofA Sees Revenue Challenges Ahead - GuruFocus
Hims and Hers stock price target maintained at $28 by BofA amid weak order trends - Investing.com
Promising Healthcare Stocks Worth WatchingOctober 9th - MarketBeat
How Hims & Hers founder Joe Spector turned 10 failures into $1B idea - Yahoo Finance
Hims & Hers Expands Personalized Care Access Via Telehealth Platform - Yahoo Finance
Hims & Hers survey: 94% of customers rate telehealth care equal to in-person - Investing.com Canada
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office - Hims Investor Relations
Abel Hall LLC Purchases Shares of 4,993 Hims & Hers Health, Inc. $HIMS - MarketBeat
Robeco Institutional Asset Management B.V. Trims Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Is Hims & Hers Health Still Attractive After FDA Scrutiny Over Super Bowl Ad? - Yahoo Finance
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives - MSN
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And Partnerships - Seeking Alpha
Will Hims’ (HIMS) Leadership Shift Reveal New Strengths in Operational Execution? - Yahoo
10 Hot Stocks Sparking Buying Frenzy - Insider Monkey
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 11,595 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading 5.8% HigherHere's What Happened - MarketBeat
Hims & Hers CFO Okupe sells $669k in shares - Investing.com
Best Healthcare Stocks To Follow NowOctober 7th - MarketBeat
Hims & Hers: Are New Health Products Boosting Stocks? - StocksToTrade
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts? - TipRanks
111 Capital Sells 6,970 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Shares Sold by QRG Capital Management Inc. - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Recent Price Surge - Quiver Quantitative
Why Hims & Hers Stock Slipped Today - MSN
HIMS Stock Dips Following Executive Transition Announcement - GuruFocus
U.S. Indexes Ended Friday Mixed As Rigetti Computing Led, Hims & Hers Health Lagged - Barron's
$HIMS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Weatherford Democrat
Hims & Hers Expands Health Access Through Subscription Revenue Model - Yahoo Finance
Evaluating Hims & Hers Health (HIMS) Valuation After 39% Share Price Surge in the Past Month - Yahoo Finance
Matauro LLC Invests $446,000 in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health (NYSE:HIMS) Stock Price Down 5.4%Time to Sell? - MarketBeat
Hims & Hers Health names new COO - Seeking Alpha
Hims & Hers Health Announces COO Transition - TipRanks
Hims & Hers Health says Nader Kabbani to step into advisory role on November 2SEC filing - MarketScreener
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares - MSN
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hims Hers Health Inc Stock (HIMS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | Chief Financial Officer |
Oct 03 '25 |
Option Exercise |
7.15 |
11,595 |
82,919 |
81,827 |
| Okupe Oluyemi | Chief Financial Officer |
Oct 03 '25 |
Sale |
57.72 |
11,595 |
669,232 |
70,232 |
| Chi Michael | Chief Commercial Officer |
Oct 01 '25 |
Option Exercise |
11.53 |
250 |
2,882 |
291,689 |
| Chi Michael | Chief Commercial Officer |
Oct 01 '25 |
Sale |
56.00 |
250 |
14,000 |
291,439 |
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):